Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Grimwade

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
British Journal of Haematology|November 25, 1998
Salvage of patients with acute promyelocytic leukaemia with residual disease following ABMT performed in second CR using all-trans retinoic acidD Grimwade, R Jamal, N Goulden, et al.
Leukemia|January 1, 1996
Minimal residual disease detection in acute promyelocytic leukemia by reverse-transcriptase PCR: evaluation of PML-RAR alpha and RAR alpha-PML assessment in patients who ultimately relapseD Grimwade, K Howe, S Langabeer, et al.
Blood|June 11, 1999
Presenting white blood cell count and kinetics of molecular remission predict prognosis in acute promyelocytic leukemia treated with all-trans retinoic acid: result of the Randomized MRC TrialA K Burnett, D Grimwade, E Solomon, et al.
Leukemia & Lymphoma|September 1, 1992
Tumour lysis following hydrocortisone prior to a blood product transfusion in T-cell acute lymphoblastic leukaemiaC Tiley, D Grimwade, M Findlay, et al.
Bone Marrow Transplantation|June 1, 1997
What happens subsequently in AML when cytogenetic abnormalities persist at bone marrow harvest? Results of the 10th UK MRC AML trial. Medical Research Council Leukaemia Working PartiesD Grimwade, H Walker, F Oliver, et al.
International Journal of Sports Medicine|November 28, 2012
The validity of the ActiPed for physical activity monitoringD K Brown, D Grimwade, D Martinez-Bussion, et al.
Leukemia|July 2, 2013
Hyperdiploidy with 49-65 chromosomes represents a heterogeneous cytogenetic subgroup of acute myeloid leukemia with differential outcomeL Chilton, R K Hills, C J Harrison, et al.
British Journal of Haematology|December 1, 1995
The metabolites of nitric oxide in sickle-cell diseaseD C Rees, P Cervi, D Grimwade, et al.
Annals of Hematology|May 6, 2004
Impact of karyotype on treatment outcome in acute myeloid leukemiaD Grimwade, A Moorman, R Hills, et al.
British Journal of Haematology|June 3, 1998
A study to determine whether trisomy 8, deleted 9q and trisomy 22 are markers of cryptic rearrangements of PML/RARalpha, AML1/ETO and CBFB/MYH11 respectively in acute myeloid leukaemia. MRC Adult Leukaemia Working Party. Medical Research CouncilS E Langabeer, D Grimwade, H Walker, et al.
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
British Journal of Haematology|November 25, 1998
Salvage of patients with acute promyelocytic leukaemia with residual disease following ABMT performed in second CR using all-trans retinoic acidD Grimwade, R Jamal, N Goulden, et al.
Leukemia|January 1, 1996
Minimal residual disease detection in acute promyelocytic leukemia by reverse-transcriptase PCR: evaluation of PML-RAR alpha and RAR alpha-PML assessment in patients who ultimately relapseD Grimwade, K Howe, S Langabeer, et al.
Blood|June 11, 1999
Presenting white blood cell count and kinetics of molecular remission predict prognosis in acute promyelocytic leukemia treated with all-trans retinoic acid: result of the Randomized MRC TrialA K Burnett, D Grimwade, E Solomon, et al.
Leukemia & Lymphoma|September 1, 1992
Tumour lysis following hydrocortisone prior to a blood product transfusion in T-cell acute lymphoblastic leukaemiaC Tiley, D Grimwade, M Findlay, et al.
Bone Marrow Transplantation|June 1, 1997
What happens subsequently in AML when cytogenetic abnormalities persist at bone marrow harvest? Results of the 10th UK MRC AML trial. Medical Research Council Leukaemia Working PartiesD Grimwade, H Walker, F Oliver, et al.
International Journal of Sports Medicine|November 28, 2012
The validity of the ActiPed for physical activity monitoringD K Brown, D Grimwade, D Martinez-Bussion, et al.
Leukemia|July 2, 2013
Hyperdiploidy with 49-65 chromosomes represents a heterogeneous cytogenetic subgroup of acute myeloid leukemia with differential outcomeL Chilton, R K Hills, C J Harrison, et al.
British Journal of Haematology|December 1, 1995
The metabolites of nitric oxide in sickle-cell diseaseD C Rees, P Cervi, D Grimwade, et al.
Annals of Hematology|May 6, 2004
Impact of karyotype on treatment outcome in acute myeloid leukemiaD Grimwade, A Moorman, R Hills, et al.
British Journal of Haematology|June 3, 1998
A study to determine whether trisomy 8, deleted 9q and trisomy 22 are markers of cryptic rearrangements of PML/RARalpha, AML1/ETO and CBFB/MYH11 respectively in acute myeloid leukaemia. MRC Adult Leukaemia Working Party. Medical Research CouncilS E Langabeer, D Grimwade, H Walker, et al.
Pageof 5